GSK plc (GSK) Debt to Equity Ratio
GSK plc (GSK) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2016-12-31 | 3.77 |
| 2017-12-31 | 4.88 |
| 2018-12-31 | 7.08 |
| 2019-12-31 | 1.59 |
| 2020-12-31 | 1.25 |
| 2021-12-31 | 1.09 |
| 2022-12-31 | 2.08 |
| 2023-12-31 | 1.41 |
| 2024-12-31 | 1.30 |
| 2025-12-31 | 1.11 |
Debt to equity divides total borrowings by total shareholder equity at the period end. Total borrowings are short-term debt plus long-term debt, including capital lease obligations. Non-debt liabilities such as accounts payable and deferred revenue are excluded. A period is omitted when equity is negative, because the ratio is not meaningful then.
Get GSK plc Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("GSK", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | GSK | $52.41 | +0.87% | 2.39M |
| 3 | ||||
| 4 | ||||
| 5 |